Protalix BioTherapeutics
PLX
PLX
45 hedge funds and large institutions have $3.53M invested in Protalix BioTherapeutics in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 20 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
75% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 20
78% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 27
Holders
45
Holding in Top 10
–
Calls
$62K
Puts
$37K
Top Buyers
| 1 | +$275K | |
| 2 | +$154K | |
| 3 | +$74.7K | |
| 4 |
SA
Sanctuary Advisors
Indianapolis,
Indiana
|
+$62.7K |
| 5 |
VF
Virtu Financial
New York
|
+$44K |
Top Sellers
| 1 | -$446K | |
| 2 | -$420K | |
| 3 | -$378K | |
| 4 |
Jane Street
New York
|
-$249K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$185K |